China Nepstar Chain Drugstore (NPD) Reports In-Line Q1 Loss

China Nepstar Chain Drugstore (NYSE: NPD) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue increased by 11.9% to RMB759.1 million (US$122.5 million) compared to RMB678.3 million in the first quarter of 2014

Same store sales increased by 13.6% compared to the first quarter of 2014

For earnings history and earnings-related data on China Nepstar Chain Drugstore (NPD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c